Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. by Jubb, A, Miller, K, Rugo, H, Harris, A, Chen, D, Reimann, J, Cobleigh, M, Schmidt, M, Langmuir, V, Hillan, K, Chen, D, Koeppen, H